Endothelial Dysfunction, Impaired Endogenous Fibrinolysis, and Cigarette Smoking
- 23 March 1999
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (11) , 1411-1415
- https://doi.org/10.1161/01.cir.99.11.1411
Abstract
Background —Effective endogenous fibrinolysis requires rapid release of tissue plasminogen activator (tPA) from the vascular endothelium. Smoking is a known risk factor for arterial thrombosis and myocardial infarction, and it causes endothelial dysfunction. We therefore examined the effects of cigarette smoking on substance P–induced tPA release in vivo in humans. Methods and Results —Blood flow and plasma fibrinolytic factors were measured in both forearms of 12 smokers and 12 age- and sex-matched nonsmokers who received unilateral brachial artery infusions of substance P (2 to 8 pmol/min). In both smokers and nonsmokers, substance P caused dose-dependent increases in blood flow and local release of plasma tPA antigen and activity ( P P =0.03) and release of tPA antigen ( P =0.04) and activity ( P Conclusions —Cigarette smoking causes marked inhibition of substance P–induced tPA release in vivo in humans. This provides an important mechanism whereby endothelial dysfunction may increase the risk of atherothrombosis through a reduction in the acute fibrinolytic capacity.Keywords
This publication has 40 references indexed in Scilit:
- Intra‐arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerabilityBritish Journal of Clinical Pharmacology, 1997
- Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal WomenNew England Journal of Medicine, 1997
- How do smokers differ from nonsmokers in their response to thrombolysis? (The TIMI-4 trial)The American Journal of Cardiology, 1995
- Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarctionThe American Journal of Cardiology, 1993
- Impaired Forearm Vasodilator Reserve in Patients with Microvascular AnginaNew England Journal of Medicine, 1987
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Variation in serum lipid and lipoprotein levels associated with changes in smoking behaviour in non-obese caucasian malesAtherosclerosis, 1985
- Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator.Circulation, 1985
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980